Introduction Although antimicrobials have traditionally been used to treat infections and
improve health outcomes, resistance to commonly used antimicrobials has posed a major …

Worldwide, Pseudomonas aeruginosa remains a leading nosocomial pathogen that is
difficult to treat and constitutes a challenging menace to healthcare systems. P. aeruginosa …

Although pathogenic bacteria are the targets of antibiotics, these drugs also affect hundreds
of commensal or mutualistic species. Moreover, the use of antibiotics is not only restricted to …

Background/Purpose Some multidrug-resistant gram-negative bacteria as a global threat
have been recently prioritized for research and development of new treatments. We studied …

Pseudomonas aeruginosa is a high-priority bacterial agent that causes healthcare-acquired
infections (HAIs), which often leads to serious infections and poor prognosis in vulnerable …

Pseudomonas aeruginosa (PA) is a leading nosocomial pathogen and has great versatility
due to a complex interplay between antimicrobial resistance and virulence factors. PA has …

Objectives Pseudomonas aeruginosa has intrinsic antibiotic resistance and the strong ability
to acquire additional resistance genes. However, a limited number of investigations provide …

When grown on agar surfaces, microbes can produce distinct multicellular spatial structures
called colonies, which contain characteristic sizes, shapes, edges, textures, and degrees of …

Antimicrobial resistance is presently one of the greatest threats to public health. The
excessive and indiscriminate use of antibiotics imposes a continuous selective pressure that …

Pseudomonas aeruginosa ST274 is an international epidemic high-risk clone, mostly
associated with hospital settings and appears to colonize cystic fibrosis (CF) patients …